Supernus Pharmaceuticals, Inc. (SUPN)

54.55 -0.54 (-0.98%) USD  |  NASDAQ  |  Mar 03, 16:00
More

Supernus Pharmaceuticals Total Equity Including Minority Interest (Quarterly)

Total Equity Including Minority Interest (Quarterly) Chart

View Total Equity Including Minority Interest (Quarterly) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Equity Including Minority Interest (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Equity Including Minority Interest (Quarterly) Range, Past 5 Years

View Total Equity Including Minority Interest (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Equity Including Minority Interest (Quarterly) Benchmarks

View Total Equity Including Minority Interest (Quarterly) Benchmarks
Start Trial
Biogen, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Cytokinetics, Inc. Upgrade